Circulating cell-free tumour DNA in the management of cancer

Loading...
Thumbnail Image
File version

Version of Record (VoR)

Author(s)
Francis, G
Stein, S
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2015
Size
File type(s)
Location
Abstract

With the development of new sensitive molecular techniques, circulating cell-free tumour DNA containing mutations can be identified in the plasma of cancer patients. The applications of this technology may result in significant changes to the care and management of cancer patients. Whilst, currently, these “liquid biopsies” are used to supplement the histological diagnosis of cancer and metastatic disease, in the future these assays may replace the need for invasive procedures. Applications include the monitoring of tumour burden, the monitoring of minimal residual disease, monitoring of tumour heterogeneity, monitoring of molecular resistance and early diagnosis of tumours and metastatic disease.

Journal Title

International Journal of Molecular Sciences

Conference Title
Book Title
Edition
Volume

16

Issue

6

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).

Item Access Status
Note
Access the data
Related item(s)
Subject

Other chemical sciences

Genetics

Genetics not elsewhere classified

Other biological sciences

Persistent link to this record
Citation
Collections